place important constraints on the possibilities for the genetic-basis underlying susceptibility to multiple sclerosis (MS). Methods: Using very broad range-estimates for the different population ...

Multiple sclerosis (MS) is one of the most widespread ... Researchers still don’t fully understand the cause of MS or why the rate of progression is so difficult to determine.

Researchers don’t yet fully understand what causes multiple sclerosis (MS) but believe it may develop from a combination of genetic and environmental factors. Identifying these factors can help ...

In basic terms, scientists simply don’t know what causes multiple sclerosis, or MS. Your genes play at least some part. MS doesn’t have a cure, but strong evidence shows that viruses may ...

People with multiple sclerosis (MS ... the mechanisms involved in the disease process, the cause remains unknown. Theories include genetics or infections. Different environmental risk factors ...

Multiple sclerosis (MS) is a progressive autoimmune disease that affects the brain and spinal cord, impacting 2.8 million people globally. It causes chronic inflammation that damages the myelin sheath ...

Nov. 18, 2024 — Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in ...

Here are the multiple sclerosis symptoms females ... Experts aren’t exactly sure what causes MS, but they think it involves a combination of genetic, environmental, and lifestyle factors.

Severe obesity in childhood and adolescence more than triples the risk of MS, and obesity treatment does not seem to reverse it, a study finds.

A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...

Although the precise etiology of multiple sclerosis is still unknown, it is thought to be the result of a confluence of environmental and genetic variables. The complex relationship of these ...

Multiple sclerosis (MS) is the most common cause of disability in young adults ... In the laboratory we are investigating ex-vivo gene therapies to enhance the efficacy of AHSCT and have developed ...